Hutch News

Hutch News

Stories tagged 'Pathogen-Associated Malignancies IRC'

H. pylori test hints at risk factor for stomach cancer

Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer

Sept. 12, 2018 | By Sabrina Richards / Fred Hutch News Service

A pilot study by Dr. Nina Salama at Fred Hutch hints that carrying a specific strain of H. pylori could be a risk factor for stomach cancer in East Asian patients.

View story >


Galloway and Hartwell to enter Washington Life Science Hall of Fame

Awards recognize power of basic research, leadership in driving advances for patients

March 27, 2018 | By Sabrina Richards / Fred Hutch News Service

Basic researchers Drs. Denise Galloway and Lee Hartwell to enter Washington Life Science Hall of Fame.

View story >


Jump-starting innovative projects exploring pathogen-associated cancers

Pathogen-Associated Malignancies Integrated Research Center awards first round of pilot funding supporting researchers studying H. pylori, EBV and the microbiome

March 16, 2018 | By Sabrina Richards

Announcing the inaugural recipients of the PAM IRC Innovation Awards for innovative projects exploring pathogens associated with cancer.

View story >


For cancer patients with HIV, immunotherapy appears safe

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials

Nov. 7, 2017 | By Mary Engel / Fred Hutch News Service

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 5, 2017

Thanks to robust community support, Fred Hutch vanity plates are now available. For every set of plates sold, the Hutch receives $28 to support its lifesaving, innovative science.

View story >


Why Fred Hutch President Gary Gilliland is enlisting techies to defeat cancer by 2025

Sept. 26, 2017 | By Alan Boyle / GeekWire

Fred Hutch President and Director Gary Gilliland is bringing big-data experts on board to make good on his prediction that there could be cures and therapies for “most, if not all, human cancers” by 2025.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.